Does IMATINIB Cause Bronchopulmonary aspergillosis? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Bronchopulmonary aspergillosis have been filed in association with IMATINIB (Imatinib). This represents 0.1% of all adverse event reports for IMATINIB.
43
Reports of Bronchopulmonary aspergillosis with IMATINIB
0.1%
of all IMATINIB reports
19
Deaths
24
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From IMATINIB?
Of the 43 reports, 19 (44.2%) resulted in death, 24 (55.8%) required hospitalization, and 9 (20.9%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which IMATINIB Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL